Abstract:Injectable biomaterials are attractive for soft tissue regeneration because they are handled in a minimally invasive manner and can easily adapt to complex defects. However, inadequate vascularization of the injectable constructs has long been a barrier, leading to necrosis or volume reduction after implantation. In this work, we developed a three-step process to synthesize injectable gelatin-derived hydrogels that are capable of controlling growth factor delivery to induce angiogenesis. In our approach, tyramine was first introduced into gelatin chains to provide enzymatic crosslinking points for gel formation after injection. Next, heparin, a polysaccharide with binding domains to many growth factors, was covalently linked to the tyramine-modified gelatin. Finally, vascular endothelial growth factor (VEGF) was incorporated into the gelatin derivative by binding with the heparin in the gelatin derivative, and an injectable gel with controlled VEGF release was formed by an enzymatic catalytic reaction with hydrogen peroxide (H2O2) and horseradish peroxidase (HRP). The gelation time, mechanical properties and degradation of the gel was readily tailored by the gelatin concentration and the ratio of H2O2/HRP. Binding VEGF to heparin stabilizes this growth factor, protects it from denaturation and proteolytic degradation and subsequently prolongs the sustained release. An in vitro release study and bioactivity assay indicated that the VEGF was released in a sustained manner with high bioactivity for over 3 weeks. Furthermore, a chicken chorioallantoic membrane (CAM) assay and animal experiments were performed to evaluate in vivo bioactivity of the VEGF released from the hydrogels. After 5 days of incubation on CAM, the number of blood vessels surrounding the heparin-modified hydrogels was increased by 2.4-fold compared with that of the control group. Deeper and denser cell infiltration and angiogenesis in the heparin-modified gelatin/VEGF gels were observed compared to the controls after being subcutaneously injected in the dorsal side of the mice for 2 weeks. Interestingly, even without the incorporation of VEGF, the heparin-modified gelatin derivative still had the capability to induce angiogenesis to a certain degree. Our results suggest that the gelatin derivative/VEGF is an excellent injectable delivery system for induced angiogenesis of soft tissue regeneration.

Preparation and Characterization of a VEGF-Fc Fusion Protein Matrix for Enhancing HUVEC Growth

Human VE-Cadherin Fusion Protein as an Artificial Extracellular Matrix Enhancing the Proliferation and Differentiation Functions of Endothelial Cell

VEGF-Fc delivery scaffold for promoting angiogenesis in biomaterials

Effects of artificial extracellular matrixes on the survival of vascular endothelial cells

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Enhanced Vascularization of PCL Porous Scaffolds Through VEGF-Fc Modification

The Immobilization of Vegf-Fc for Promoting Endothelial Cells Proliferation in Porous Pcl Scaffolds

VE-cadherin functionalized injectable PAMAM/HA hydrogel promotes endothelial differentiation of hMSCs and vascularization

Enhanced Vascular-like Network Formation of Encapsulated HUVECs and ADSCs Coculture in Growth Factors Conjugated GelMA Hydrogels.

Functional Modification of Fibrous PCL Scaffolds with Fusion Protein HGFI-VEGF Enhanced Cellularization and Vascularization

Functional Modification of Fibrous PCL Scaffolds with Fusion Protein VEGF-HGFI Enhanced Cellularization and Vascularization.

The effects of biomimetically conjugated VEGF on osteogenesis and angiogenesis of MSCs (human and rat) and HUVECs co-culture models

Enhanced Vascularization in Hybrid PCL/Gelatin Fibrous Scaffolds with Sustained Release of VEGF

Poly(ε-caprolactone)/keratin/heparin/VEGF Biocomposite Mats for Vascular Tissue Engineering.

A HUVEC Line with a Stable Expression of the VEGF121 Gene to Achieve Complete Endothelialization of Blood Conduits

Injectable EC-BMSC hydrogel with prolonged VEGF action for enhanced angiogenesis

[Preliminary Study on the Effect of Vascular Endothelial Growth Factor-Loaded Self-Assembled Peptide Hydrogel on Angiogenesis and Vascularization of Human Umbilical Vein Endothelial Cells].

Extracellular Matrix Mimicking Nanofibrous Scaffolds Modified With Mesenchymal Stem Cell-Derived Extracellular Vesicles for Improved Vascularization

Proliferation and Migration of Human Vascular Endothelial Cells Mediated by ZNF580 Gene Complexed with Mpeg-B-p(mmd-co-ga)-g-pei Microparticles

Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis

Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells